Ultragenyx Pharmaceutical
RARE
RARE
300 hedge funds and large institutions have $4.82B invested in Ultragenyx Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 112 increasing their positions, 92 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 274 → 300 (+26)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3.13% less ownership
Funds ownership: 97.4% → 94.27% (-3.1%)
Holders
300
Holding in Top 10
6
Calls
$28.2M
Puts
$23.9M
Top Buyers
| 1 | +$56M | |
| 2 | +$48.3M | |
| 3 | +$39.2M | |
| 4 |
Two Sigma Advisers
New York
|
+$27.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$20.7M |
Top Sellers
| 1 | -$65.8M | |
| 2 | -$58.1M | |
| 3 | -$53.5M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$46.4M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$27.3M |